BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
340761
Number of visits today
31
Number of downloads
100221
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Ahmed S, Khan H, Fakhri S, Aschner M, Cheang WS. Therapeutic potential of marine peptides in cervical and ovarian cancers. Mol Cell Biochem 2021. [PMID: 34855045 DOI: 10.1007/s11010-021-04306-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chang L, Wu X, Ran K, Tian Y, Ouyang X, Liu H, Gou S, Zhang Y, Ni J. One New Acid-Activated Hybrid Anticancer Peptide by Coupling with a Desirable pH-Sensitive Anionic Partner Peptide. ACS Omega 2023;8:7536-45. [PMID: 36873017 DOI: 10.1021/acsomega.2c06766] [Reference Citation Analysis]
2 Trinidad-Calderón PA, Varela-Chinchilla CD, García-Lara S. Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials. Molecules 2023;28. [PMID: 36677728 DOI: 10.3390/molecules28020670] [Reference Citation Analysis]
3 Lv C, Ren C, Yu Y, Yin H, Huang C, Yang G, Hong Y. Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells. Nutrients 2022;14:3790. [DOI: 10.3390/nu14183790] [Reference Citation Analysis]
4 Zhang Y, Chang L, Bao H, Wu X, Liu H, Gou S, Zhang J, Ni J. Constructing New Acid-Activated Anticancer Peptide by Attaching a Desirable Anionic Binding Partner Peptide. J Drug Target 2022;:1-26. [PMID: 35502656 DOI: 10.1080/1061186X.2022.2070627] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345